The spread of the COVID-19 epidemic has basically ended in China, though it is not completely over, according to a senior health expert, quoted on the website of the country’s National Medical Products Administration (NMPA).
Liang Wannian, head of the National Health Commission's expert panel on COVID-19 control, said the "decisive victory" in COVID-19 epidemic control, announced at a recent meeting of the Standing Committee of the Political Bureau of the Communist Party of China Central Committee, means that the country has withstood the impact and test of the recent outbreak, with its people achieving herd immunity.
Although COVID-19 remains an international health emergency, China has set an example of a highly populous nation successfully pulling through a pandemic, he said at a news conference.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze